会议

更新时间:2023-07-09 04:08:45 阅读: 评论:0

分会1——生物技术产业化与科技金融
Date  日期
Time  时间
Agenda  议程
Monday
星期一
June 27
627
Venue
地点
Co-Chairs
主持
N220, 2F, Tianjin Meijiang Convention and Exhibition Center
天津梅江会展中心2N220
DENG Tianzuo, Associate Counl, Department of Facilities and Financial Support, The Ministry of Science and Technology of China
邓天佐,科技部科研条件与财务司,副巡视员
HE Wei, Director General, Department of Science, Technology and Education, The Ministry of Health of China
何维,卫生部科技教育司,司长
09:00-09:15
Welcome Speech, Leader from Department of Facilities and Financial Support, The Ministry of Science and Technology of China
科技部条件财务司领导致欢迎词
09:15-09:45
SpeakerHE Wei, Director General, Department of Science, Technology and Education, The Ministry of Health of China
Titleto be confirmed
报告人:何维,卫生部科技教育司,司长
报告题目:待定
09:45-10:15
SpeakerZHANG Qingkui, General Director, Pharmaceutical and Biological Department, State Intellectual Property Office of the People’s Republic of China
TitleStrategy for Intellectual Property in Biological Field And Information for Investigation
报告人:张清奎,国家知识产权局医药生物审查部,部长
报告题目:生物产业知识产权战略及投融资须知
化无
10:15-10:30
Coffee Break  茶歇
10:30-11:00
SpeakerMA Hongjian, Deputy Director , China National Center for Biotechnology Development
Title The Strategy and Prospect of the 12th five year for Biotechnology Development in China
报告人:马宏建,科技部中国生物技术发展中心,副主任
报告题目:“十二五”中国生物技术发展策略与展望
11:00-11:30
SpeakerLIU Yong, Director, Business Development Bureau, China Development Bank
TitleSupporting Bioindustry with Open Finance
报告人:刘勇,国家开发银行评审二局,处长/高级工程师
报告题目:以开放性金融支持生物产业
11:30-12:00
SpeakerWANG Changlin, Director, Institute of Industrial Economy and Technical Economy Academy of Macroeconomic Rearch, NDRC
TitleThe Main Task and The Policy Suggestions of The 12th Five Year for Bioindustry Development in China
报告人:王昌林,国家发改委宏观院产业所,所长
报告题目:“十二五”时期生物产业发展主要任务与政策措施建议
12:00-13:30
Lunch  午餐
Co-Chairs
主持
YANG Shengli, Academician, Shanghai Institutes for Biological Science, Chine Academy of Sciences
杨胜利,中国科学院上海生命科学研究院,院士
Hank Nordhoff, Chairman, Gen-Probe
Hank Nordhoff, Gen-Probe公司 董事长,
13:30-14:00
SpeakerHank Nordhoff, Chairman, Gen-Probe
TitleThe Evolution of Diagnostics: From Body Temperature to Biomarkers
报告人:Hank NordhoffGen-Probe公司,董事长,
报告题目:诊断的发展:从体温到生物标志物
14:00-14:30
SpeakerDuane Roth, CEO, CONNECT & ROTH Capital, U.S.A
TitleDistributed Partnering
报告人:Duane RothCONNECT & ROTH Capital 投资公司,首席执行官
报告题目:分布式的合作
14:30-15:00
SpeakerCHEN Yisong, CEO & President, Pallas Global Capital LLC
TitleThe Trend in Biotech Industry Investment and Some Thinking in Investment and Policy
报告人:陈毅松,德通寰球资本有限公司,首席执行官/总裁
报告题目:生物产业的投资趋势和一些投资及政策思考
15:00-15:30
SpeakerTing Pau OeiPartnerL Capital Partners
TitleThe Role of Venture Capital in Financing Biotechnology
报告人:Ting Pau OeiL Capital Partners投资公司,合伙人
报告题目:风险投资在生物技术融资中的作用
15:30-15:45
Coffee Break  茶歇
15:45-16:15
SpeakerJIANG Feng, President, China Innovation Strategic Alliance of Medical Devices
TitleReflections of The Science and Technology Finance in The Medical Device Industry
报告人:姜峰,科技部医疗器械产业技术创新联盟,理事长
报告题目:医疗器械产业科技金融的几点思考
16:15-16:45
SpeakerDAI Xiaochang, Managing Partner, Shanghai HPI LLP
Title Angel Investors to GEM——Venture Capital Boost Bioindustry
报告人:戴晓畅,上海衡康投资管理合伙企业,执行合伙人
报告题目:天使投资到创业板——风险资本助推生物产业
16:45-17:15
SpeakerZHANG Shiyuan, Chief Rearcher, Southwest Securities Co., Ltd.
TitleTransformation Promotes Bioindustry Development
报告人:张仕元,西南证券有限责任公司,首席研究员
报告题目:变革推动生物产业进入繁荣期
18:30-19:30
Dinner  晚餐
分会2——前沿生物技术分会
日期(Date
时间表(Time Slot
议程(Agenda
2011627, 星期一
(June 27th, 2011. Monday)
Venue
地点
Co-Chairs
主持
N211, 2F, Tianjin Meijiang Convention and Exhibition Center
天津梅江会展中心2N211
RAO Zihe, Tsinghua University/Nankai University/Institute of Biophysics,CAS
饶子和院士,清华大学/南开大学/中科院生物物理所
Raymond C. Stevens, Departments of Molecular Biology and Chemistry, The Scripps Rearch Institute, La Jolla, California, USA
Raymond C. Stevens教授,美国 Scripps 研究所
09:00-09:30
SpeakerProfessor George F Gao, Institute of Microbiology, Chine Academy of Sciences
Title2009 Pandemic influenza virus: what special for its HA and NA
报告人:高福,中国科学院微生物研究所,教授
报告题目:2009甲型H1N1流感病毒囊膜蛋白HANA的结构特异性
09:30-10:00
SpeakerProfessor Ian Jones, School of Biological Sciences, University of Reading, United Kingdom
TitleNext generation vaccines produced in inct cells
报告人:Ian Jones ,英国雷丁大学生命科学学院,教授
报告题目:利用昆虫细胞生产的新一代疫苗
10:00-10:30
SpeakerProfessor ZHOU Qi, Institute of Zoology, Chine Academy of Sciences
TitleProgress and potential application of Stem Cell Rearch and Regenerative Medicine
报告人:周琪,中国科学院动物研究所,教授
报告题目:干细胞及再生医学研究进展及潜在应用
10:30-10:45
茶歇(Coffee Break
10:45-11:15
SpeakerProfessor Thomas Kay, St. Vincent’s Institute, Australia
TitleNew Technologies to Treat Type 1 Diabetes
报告人: Thomas Kay ,澳大利亚St. Vincent’s 研究所,教授
报告题目:治疗1型糖尿病的新技术
11:15-11:45
SpeakerRaymond C. Stevens, Departments of Molecular Biology and Chemistry, The Scripps Rearch Institute, La Jolla, California, USA
TitleNew Drug Discovery Paradigms for G-protein Coupled Receptors
报告人: Raymond C. Stevens,美国 Scripps 研究所,教授
报告题目: G蛋白偶联受体的新型药物开发模式
11:45-12:15
SpeakerProfessor  WANG Xiaoning
TitleTalent, Team and the R&D
报告人:王小宁,教授
报告题目:人才、团队、与产业发展
12:15-13:30
午餐(Lunch
Co-Chairs
主持
Professor ZHANG Zhuohua , Central south University
张灼华,中南大学,教授
14:00-14:30
SpeakerProfessor HE Lin, The Bio-X Center, Shanghai Jiao Tong University
TitleThe Effects of Food and Drug on Earlier Stage Prevention from Dias
报告人:贺林,上海交通大学Bio-X中心/复旦大学/上海生科院营养科学研究所,院士
报告题目:食品与药品在疾病预防关口前移中的作用
14:30-15:00
SpeakerProfessor Neil Isaacs, University of Glasgow, UK
TitleLearning from Nature – Using Molecular Structures as Design Templates
报告人:Neil Isaacs,英国格拉斯哥大学,教授
报告题目:来自自然的启发: 利用分子结构作为设计模板
15:00-15:30
SpeakerProfessor Barbara Howlett, School of Botany, the University of Melbourne, Vic 3010
TitleExploiting the genome quence of a fungal pathogen to minimize plant dia
报告人:Barbara Howlett,墨尔本大学植物学院,教授
报告题目:通过探索真菌病原体的基因组序列来减少植物病虫害
15:30-15:45
茶歇 Coffee Break
15:45-16:15
SpeakerProfessor ZHANG Hong,National Institute of Biological Sciences
TitleAutophagy in the pathogenesis of dia
报告人:张宏,北京生命科学研究所,教授
报告题目:细胞自噬和疾病的发生
16:15-16:45
SpeakerProfessor Peter Colman, The Walter and Eliza Hall Institute of Medical Rearch
TitleNeuraminida inhibitors for treatment and prophylaxis of influenza: discovery and characteristics
报告人:Peter Colman,澳大利亚The Walter and Eliza Hall 医学研究所,教授
报告题目:用于治疗和预防流感的神经氨酸苷酶抑制剂的发现和特性
16:45-17:15
SpeakerProfessor ZHANG Zhuohua, Central south University
TitleConnexin-31 Dias: from Gene to Treatment
报告人:张灼华,中南大学,教授
报告题目: Connexin-31疾病:从基因到治疗
17:15-17:45
Speaker小商人Professor Geoffrey Howlett, Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne
TitleLipid Modulators of Amyloid Fibril Formation in Dia
报告人:Geoffrey Howlett ,墨尔本大学,教授
报告题目:疾病中类淀粉样纤维形成的脂类调解因子
17:45-18:15
SpeakerProfessor Bob Sim, Oxford University
TitleAdvances in monitoring function and pharmacological control of the innate immune system.
报告人:Bob Sim,英国牛津大学,教授
报告题目:先天性免疫系统中监控机制及药物控制的研究新进展
18:30-19:30
晚餐 Dinner
分会3——农业生物技术分会
史铁生简介
Date  日期
Time  时间
Agenda  议程
Monday
星期一
June 27
627
Venue
地点
Co-Chairs
主持
N217, 2F, Tianjin Meijiang Convention and Exhibition Center
天津梅江会展中心2N217
LI Ning, Academician, China Agricultural University
Laible Goetz,Professor,Agrearch
李宁,中国农业大学,院士
Laible Goetz,新西兰Ag研究所,教授
09:00-09:25
SpeakerLaible Goetz,Professor,Agrearch
TitleCell-mediated transgenesis of livestock for biopharming and improved dairy products.
报告人:Laible Goetz,新西兰Ag研究所,教授
报告题目:利用细胞介导的转基因家畜在生物医药和奶产品改良方面的应用。
09:25-09:50
SpeakerZHAO Yaofeng ,Professor,China Agricultural University
TitleMultiplication of Human lactoferrin transgenic cattle and safety evaluation of the resultant milk
报告人:赵要风,中国农业大学,教授
报告题目:转人乳铁蛋白基因奶牛的规模化生产
09:50-10:10
Coffee Break  茶歇
10:10-10:35
SpeakerLV Yuping ,Director,Department of Biotechnology,Beijing DBN Technology Group
TitleRearch and Development in agrobiotechnology of China
报告人:吕玉平,大北农生物技术部,主任
报告题目:智创中国农业生物技术研发
10:35-11:00
SpeakerForsberg Cecil,Professor,University of Guelph
TitleA transgenic phyta pig ready for commercialization that provides a stable platform for the addition of other beneficial traits
报告人:Forsberg Cecil,加拿大圭尔夫大学,教授
报告题目:可商业化植酸酶转基因猪的制备
11:00-11:25
SpeakerLAI Liangxue , Professor, Guangzhou Institutes of Biomedicine and Health, Chine Academy of Sciences
TitleGenetic Modification of Pigs for Human dia.
报告人:赖良学,中科院广州生物医药与健康研究院,研究员
报告题目:关于人类疾病猪的基因修饰
11:25-11:50
SpeakerZHANG Zehua , Professor, The institute of plant protection, Chine Academy of Agricultural Sciences
TitleOpportunities and Challenges of Bio-pesticide Development in China
报告人:张泽华,中国农科院植保所,研究员
报告题目:中国生物农药发展机遇与挑战
12:00-13:30
Lunch 午餐
Co-Chairs
主持
LI Ning , Academician, China Agricultural University
Laible Goetz,Professor,Agrearch
李宁,中国农业大学,院士
Laible Goetz,新西兰Ag研究所,教授
14:00-14:25
SpeakerEtches Robert, Chief Executive, Crystal Bioscience
TitleInrting modifications into the chicken genome
报告人:Etches Robert, Crystal Bioscience, 公司总经理
报告题目:鸡基因组的基因插入改造
14:25-14:50
SpeakerLAI Jinsheng ,Professor, China Agricultural University
TitleMaize genome rearch and molecular breeding
报告人:赖锦盛,中国农业大学,教授
报告题目:玉米基因组学研究与分子设计育种
14:50-15:15
SpeakerJohn McLean, General Manager of Monsanto Rearch Center, China
TitleMonsanto and Our Approach to Rearch & Development
报告人:麦科林,总经理,孟山都生物技术研究中心(中国)
报告题目:孟山都公司研发进展概况
15:15-15:35
Coffee Break  茶歇
15:35-16:00
SpeakerYU Jun ,Professor and Vice President,Beijing Institute of Genomics of Chine Academy of Sciences
TitleThe personalized Era of Human Health and Dia Rearch
报告人:于军,中国科学院北京基因组研究所,研究员,副所长
报告题目:医学、健康与疾病研究的个体化时代
16:00-16:25
SpeakerXING Yongzhong ,Professor,Huazhong Agricultural University
TitleFunctional genomics rearch and genetic improvement in rice
报告人:邢永忠,华中农业大学,教授
报告题目:水稻功能基因组研究和遗传改良
16:25-16:50
SpeakerCHEN Hualan ,Professor,Harbin Veterinary Rearch Institute ,Chine Academy of  Agricultural
TitleDevelopment and application of H5N1 avian influenza vaccines
报告人:陈化兰,中国农科院哈尔滨兽医研究所,研究员
报告题目:H5N1禽流感疫苗的研究及应用
18:30-19:30
Dinner 晚餐
分会4——医药生物技术分会
Date  日期
Time  时间
Agenda  议程
Monday
星期一
June 27
627
Venue
地点
Co-Chairs
主持
N215, 2F, Tianjin Meijiang Convention and Exhibition Center
天津梅江会展中心2N215
早的用英语怎么说
CHEN Zhinan , The Fouth Military Medical University ,Academician
陈志南,第四军医大学,院士
09:00-09:25
Speaker Frank Jiang, Sanofi-Aventis,Dr.
唐赛儿起义TitleTranslational Medicine: a critical approach in speeding up new drug RD
报告人:Frank Jiang,赛诺菲安万特,博士
报告题目:转化医学:加快新药研发的关键途径
09:25-09:50
SpeakerWEI Yuquan, Sichuan University, Academician
TitleAdvances In Gene Therapy
报告人:魏于全,四川大学,院士
报告题目:基因治疗进展
09:50-10:15
SpeakerWANG Junzhi ,National Institute for the Control of Pharmaceutical & Biological Products, Vice President
TitleBiotechnology drugs and translational medicine
报告人:王军志,中国食品药品检定研究院,副院长
报告题目:生物技术药物与转化医学
10:15-10:30
Coffee Break  茶歇
10:30-10:55
SpeakerCHEN Huipeng, Institute of Biotechnology, Academy of Military Medical Sciences of Chine PLA, Director
Title舒缓放松优美的轻音乐The Secondary Development of Protein Drugs
报告人:陈惠鹏,军事医学科学院生物工程研究所,所长
报告题目:蛋白质药物的二次开发
10:55-11:20
SpeakerJIN Li, Fudan University, Vice President
TitleLarge cohort studies in China:challenges and opportunities
报告人:金力,复旦大学,副校长
报告题目:中国的大型队列研究:机遇和挑战
11:20-11:45
SpeakerLily Yao, University of Birmingham, Dr.
TitleEconomic Evaluation of a regenerative medicine in the treatment of cartilage defects of the knee
报告人:Lily Yao,伯明翰大学,高级研究员
报告题目:关于治疗膝关节软骨缺损再生医学的经济学评价
12:00-13:30
Lunch  午餐
Co-Chairs
主持
Frank Jiang, Sanofi-Aventis,Dr.
Frank Jiang,赛诺菲安万特,博士
13:30-13:55
SpeakerCHEN Zhinan The Fouth Military Medical University,Academician
TitleProgress of Translational Medicine & Antibody Bad Biopharmaceuticals in China
报告人:陈志南,第四军医大学,院士
报告题目:基于抗体的生物制药产业与转化医学进展
13:55-14:20
SpeakerZHENG Qiang , Peking University, Professor
TitleLifecycle Quality Management of Biologics
报告人:郑强,北京大学,教授
报告题目:生物制剂全周期质量管理
14:20-14:45
SpeakerLIANG Zicai , Peking University, Professor
TitlesiRNA technology and drug development in China
报告人:梁子才,北京大学,教授
报告题目:勿以善“小”而不为:中国小核酸技术产业创新体系建设
14:45-15:10
SpeakerBradley Marchant, Sanofi-Aventis
TitleUnique opportunities for drug development in China
报告人:Bradley Marchant,赛诺菲安万特,博士
报告题目:药物研发在中国的发展良机
15:10-15:35
SpeakerSHI Jinhai, Tianjin International Joint Academy of Biotechnology & Medicine, Professor
TitleThe Safety Asssment of Monoclonal Antibody Drug
报告人:史晋海,天津国际生物医药联合研究院,副院长
报告题目:单克隆抗体药物的安全评估
15:35-15:50
Coffee Break  茶歇
15:50-16:15
SpeakerXIA Ninshao, Xiamen University, Professor
TitleCurrent situation and trend of in vitro diagnostic products
报告人:夏宁邵,厦门大学,教授
报告题目:体外诊断产品的现状与发展
16:15-16:40
SpeakerZOU Quanming , The Third Military Medical University, Professor
TitleProgress on  New Vaccine
报告人:邹全明,第三军医大学,研究员
报告题目:新型疫苗研究进展
16:40-17:05
 SpeakerMr. Sijmen de Vries, Pharming Group N.V.Leiden, the Netherlands,CEO
TitleTechnology platform for transgenic therapeutical proteins
报告人:Mr. Sijmen de VriesPharming Group N.V. ,首席执行官
报告题目:转基因治疗型蛋白技术平台
17:05-17:30
SpeakerLIU Wei, Shanghai 9th People's Hospital Affiliated to Shanghai JiaoTong University Medical School, Professor
TitleTissue engineering reach and potential product development
报告人:刘伟,上海交通大学医学院附属第九人民医院,教授
报告题目:组织工程研究和相关产品开发
18:30-19:30
Dinner  晚餐
分会5——化学药分会
Date  日期
Time  时间
Agenda  议程
Monday
星期一
June 27
627
Venue
地点
Co-Chairs
主持
N213, 2F, Tianjin Meijiang Convention and Exhibition Center
天津梅江会展中心2N213
DING Jian , Academician, General Director, Shanghai Institute of Materia Medica, CAS
LI En, General Manager, China Novartis Institutes for BioMedical Rearch Co., Ltd.
丁健,中国科学院上海药物研究所所长,院士
李恩,诺华(中国)生物医学研究有限公司总经理
08:30-09:00
SpeakerLI En , General Manager, China Novartis Institutes for BioMedical Rearch Co., Ltd.
TitleScience driven drug discovery: from target to therapy
报告人:李恩,诺华(中国)生物医学研究有限公司总经理
报告题目:科技促进药物发现:从靶标到治疗
09:00-09:30
SpeakerZHU Weiliang, Professor, Head of DDDC, Shanghai Institute of Materia Medica, CAS
Title兰蔻英文Target Identification and Lead Discovery by Using Computational Methods
报告人:朱维良,中国科学院上海药物研究所药物发现与设计中心主任,研究员
报告题目:通过计算方法的靶标确证和先导化合物发现
09:30-10:00
SpeakerLIU Changxiao, Academician, Tianjin Institute of Pharmaceutical Rearch
TitleThe role of Pharmacokinetics in translation rearch for rearch and development of new
drugs
报告人:刘昌孝,天津药物研究院,院士
报告题目:药代动力学在新药研发转换研究中的作用
10:00-10:15
Coffee Break  茶歇
10:15-10:45
SpeakerHE Wei , President & CEO, WMH Biopharma
TitleSmall Molecule Drug Innovation & Development
报告人:何伟,美国微美华药总裁兼首席执行官
报告题目:小分子药物开发和自主创新
10:45-11:15
SpeakerPeng Cho TANG, Chief Scientific Consultant, HEC Pharm Co., Ltd.
TitleINDs: US to China to US Formula for Me-better Drug Discovery in China
报告人:邓炳初,广东东阳光药业有限公司首席原创新药顾问
报告题目:新药临床研究申请:在中国模仿创新药物开发的从美国到中国再到美国方程式
11:15-11:45
SpeakerHAO Xiaojiang , Professor, Kunming Institute of Botany, CAS
TitleApproach on the Discovery of Natural Leads from Plants
报告人:郝小江,中国科学院昆明植物研究所,研究员
报告题目:植物中天然先导化合物的发现
12:00-13:30
Lunch  午餐
Co-Chairs
那海兰珠主持
DING Jian , Academician, General Director, Shanghai Institute of Materia Medica, CAS
LI En, General Manager, China Novartis Institutes for BioMedical Rearch Co., Ltd.
丁健,中国科学院上海药物研究所所长,院士
李恩,诺华(中国)生物医学研究有限公司总经理
14:00-14:30
SpeakerZHAO Shuhai , Head of Virology Chemistry, Roche R&D Center (China) Ltd
TitleDe-risking the potential of cardiovascular toxicity by rational design
报告人:赵树海,罗氏研发(中国)有限公司病毒药物化学部主管
报告题目:通过新药设计来减少心血管系统的副作用
14:30-15:00
SpeakerJIANG Jiandong , Professor, General Director, Institute of Materia Medica, Chine
Academy of Medical Sciences & Peking Union Medical College
TitleNew strategies to overcome drug-resistance in treating HBV infection
报告人:蒋建东,中国医学科学院药物研究所所长,研究员
报告题目:克服HBV病毒耐药的新策略
15:00-15:30
SpeakerYUE Guohua , President & CEO, Antagen Pharmaceuticals, Inc.
TitlePassing or Bypassing Blood Brain Barrie
报告人:岳国华,美国安塔臻制药有限公司,董事长兼首席执行官
报告题目:越过血脑屏障
15:30-15:45
Coffee Break  茶歇
15:45-16:15
SpeakerZHANG Dan , President, Fountain Medical Development Ltd.
TitleFrom bench to bed
报告人:张丹,方恩(天津)医药发展有限公司董事长
报告题目:从实验室研究到临床研究
16:15-16:45
SpeakerLV Qiang , VP of Biology, Wuxi Apptec
TitleWuXiApptec: Drug Development Platform for the Next Decade
报告人:吕强,药明康德新药开发有限公司生物研发副总裁
报告题目:药明康德:未来的新药研发平台
16:45-17:15
SpeakerHE Yun , Sr. VP and CSO, BioDuro/PPD
TitleIntegrated Drug Discovery Services in China - Opportunities and Challenges
报告人:贺耘,保诺科技(北京)有限公司,高级副总裁兼首席科学官
报告题目:中国一体化的药物发现服务——机遇和挑战
17:15-17:45
SpeakerWANG Ying , Vice President of Drug Safety, Hua Medicine Ltd.
TitleRole and Responsibility of Non-Clinical Safety Evaluation in New Drug Development
报告人:王英,华医药有限公司,药物安全与注册部副总裁
报告题目:非临床安全性评价在新药开发过程中的作用与责任
18:30-19:30
Dinner  晚餐

本文发布于:2023-07-09 04:08:45,感谢您对本站的认可!

本文链接:https://www.wtabcd.cn/fanwen/fan/82/1086657.html

版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。

标签:题目   报告   生物   药物   中国   研究
相关文章
留言与评论(共有 0 条评论)
   
验证码:
推荐文章
排行榜
Copyright ©2019-2022 Comsenz Inc.Powered by © 专利检索| 网站地图